(NasdaqGM:ADAG), SAN DIEGO and SUZHOU, China, Jan. 21, 2025 (GLOBE NEWSWIRE) — Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced it will share updated clinical data from ADG126 in microsatellite stable colorectal cancer (MSS CRC) at the ASCO Gastrointestinal (GI) Cancers Symposium in San Francisco, […]

(NASDAQ:ALXO), Webcast on January 23 at 1:00 p.m. PT/4:00 p.m. ET will review updated data from trial evaluating CD47-blocker evorpacept in HER2-positive gastric cancer SOUTH SAN FRANCISCO, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing therapies that boost the immune

(TSX-V:HEVI), CALGARY, Alberta, Jan. 21, 2025 (GLOBE NEWSWIRE) — Helium Evolution Incorporated (TSXV:HEVI) (“HEVI” or the “Company“), a Canadian-based helium exploration company focused on developing assets in southern Saskatchewan, is pleased to announce that its farm-in partner, North American Helium Inc. (“NAH“), has successfully completed drilling operations and is proceeding with casing of the joint

(NYSE:PLYM), BOSTON, Jan. 21, 2025 (GLOBE NEWSWIRE) — Plymouth Industrial REIT, Inc. (NYSE: PLYM) announced the tax treatment of its 2024 dividends to common stockholders. The following table summarizes Plymouth Industrial REIT's dividends to stockholders of Common Stock CUSIP #729640102 traded on the NYSE under ticker symbol “PLYM” for the tax year ended December 31,

(Neo:IFSS.NE), VANCOUVER, British Columbia, Jan. 21, 2025 (GLOBE NEWSWIRE) — Interfield Global Software Inc. (CBOE CA: IFSS) (the “Company” or “Interfield”) is pleased to provide the following update regarding the implementation of its previously announced MOU dated November 15, 2024 between its wholly owned subsidiary, Interfield Software Solutions LLC (“IFSS LLC”) and Abhi to integrate

(TSX:FTT), VANCOUVER, British Columbia, Jan. 21, 2025 (GLOBE NEWSWIRE) — Finning International Inc. (TSX: FTT) (“Finning”) will report Q4 and annual 2024 results on February 4, 2025 after markets close and hold the investor call on February 5, 2025 at 10:00 AM Eastern Time. To access the investor call, please dial 1-844-763-8274 (Canada and US

(NASDAQ:WTFC), ROSEMONT, Ill., Jan. 21, 2025 (GLOBE NEWSWIRE) — Wintrust Financial Corporation (“Wintrust”, “the Company”, “we” or “our”) (Nasdaq: WTFC) announced net income of $695.0 million or $10.31 per diluted common share for the year ended December 31, 2024 compared to net income of $622.6 million or $9.58 per diluted common share for the same

(NYSE:SQ), Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Block To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Block between February 26, 2020 and April 30, 2024 and would like to discuss your legal rights, call Faruqi &

(NYSE:SUI), Southfield, MI, Jan. 21, 2025 (GLOBE NEWSWIRE) — Sun Communities, Inc. (NYSE:SUI) (the “Company”) announced the tax treatment of its 2024 common share distributions. Common Shares (CUSIP No. 866674104) – SUI DeclaredDate RecordDate PayableDate Distribution($ per share) Ordinary Taxable Dividend (2)($ per share) Qualified Taxable Dividend (2)($ per share) Non Dividend Distribution($ per share)

Karmanos Cancer Institute – Dearborn offers oncology care for many types of cancer, cancer screening and prevention Today, theBarbara Ann Karmanos Cancer Institute, part of McLaren Health Care, cut the ribbon at the new Karmanos Cancer Institute – Dearborn. Located at 18800 Hubbard Drive (Dearborn, MI 48126), the cancer center occupies the main floor of